Clovis Oncology Net Income

Clovis Oncology (CLVS) currently reports a net income of $-250M as of September 2022. That compares with $-300M in the prior-year period — up 15.8% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Clovis Oncology's net income history and peer comparisons.

Clovis Oncology's net income increased from $-300M to $-250M — a 15.8% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clovis Oncology's net income of $-250M is lower than the Healthcare sector average of $16B. That is roughly 101.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Clovis Oncology reported $-250M in net income as of September 2022. That compares with $-300M in the prior-year period — up 15.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-250M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Clovis Oncology, and consider following CLVS for alerts when major investors trade the stock.